Oxford Drug Design has announced new in vivo results that further validate its emerging first‑in‑class oncology programme, ...
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding within Google parent company Alphabet, raising $600 million to advance its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback